Search the Newsreel

Truist Financial Sticks to Their Hold Rating for Evolent Health (EVH)

5 Must-Read Analyst Questions From Evolent Health’s Q2 Earnings Call

Dimensional Fund Advisors LP Has $4.08 Million Stock Position in Evolent Health, Inc $EVH

Truist Securities Adjusts Price Target on Evolent Health to $6 From $7, Keeps Hold Rating

3 Stocks Under $10 with Questionable Fundamentals

3 Stocks Under $10 with Questionable Fundamentals Stocks trading in the $1-10 range are generally smaller players with less risk than their penny stock counterparts. But that doesn't mean the underlying businesses are cheap, and we advise caution as many have questionable fundamentals. The …

Evolent Health Shares Rise After Citigroup Upgrade

Boeing upgraded, Under Armour downgraded: Wall Street's top analyst calls

Boeing upgraded, Under Armour downgraded: Wall Street's top analyst calls The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compiled by The Fly. Top 5 …

Citigroup Upgrades Evolent Health to Buy From Neutral, Adjusts PT to $6 From $6.75

Evolent Health, Inc. 2026 Q2 - Results - Earnings Call Presentation (NYSE:EVH) 2026-08-10

Key Points Interested in Evolent Health, Inc? Here are five stocks we like better. Evolent raised its 2026 outlook after Q2 revenue rose 31% sequentially to $653 million and adjusted EBITDA increased 27% to $28 million. Full-year revenue guidance is now $2.6 billion–$2.7 billion, …

Evolent Health (NYSE:EVH) Announces Quarterly Earnings Results

Evolent Health (EVH) Stock Rebounds As Growth Momentum Confronts Losses

Evolent Health (EVH) stock jumped 10% after its Q2 report, showcasing significant revenue growth despite persistent net losses. The company's future hinges on balancing its multi-year revenue expansion from Performance Suite contracts and automation with its ongoing profitability challenges and a low valuation. Investors …

Evolent Health Q2 Earnings Call Highlights

Key Points Interested in Evolent Health, Inc? Here are five stocks we like better. Evolent raised its 2026 outlook after Q2 revenue rose 31% sequentially to $653 million and adjusted EBITDA increased 27% to $28 million. Full-year revenue guidance is now $2.6 billion–$2.7 billion, …

Evolent Health Inc (EVH) (Q2 2026) Earnings Call Highlights: Revenue Surges 31% and Guidance ...

Key Points Interested in Evolent Health, Inc? Here are five stocks we like better. Evolent raised its 2026 outlook after Q2 revenue rose 31% sequentially to $653 million and adjusted EBITDA increased 27% to $28 million. Full-year revenue guidance is now $2.6 billion–$2.7 billion, …

Evolent Health (EVH) Tops Q2 Earnings and Revenue Estimates

Evolent Announces Second Quarter 2026 Results

Evolent Health (NYSE:EVH) Reports Bullish Q2 CY2026, Stock Jumps 18.2%

Evolent Health Earnings: What To Look For From EVH

Evolent Health Inc Class A (EVH) Stock Price | Live Quotes & Charts | NYSE

This page provides live stock quotes and charts for Evolent Health Inc Class A (EVH) on the NYSE, showing a current price of $4.26 and an 8.19% decrease. It also notes the absence of analyst ratings or earnings information for the company. The page …

ETFs Investing in Evolent Health Inc Class A Stocks

This article lists various Exchange Traded Funds (ETFs) that hold Evolent Health Inc Class A stocks, providing details such as market value, weight, issuer, management style, focus, expense ratio, and AUM. It highlights that ETFs can make stock investing more accessible and offer diversified …

BlackRock Portfolio Management (NYSE: EVH) discloses 5.5% Evolent Health ownership

BlackRock Portfolio Management LLC has reported a significant ownership stake in Evolent Health, Inc. Class A stock, holding 6,227,355 shares, which represents 5.5% of the outstanding Class A shares as of June 30, 2026. The firm maintains sole voting power over 5,456,212 shares and …

Strength Seen in Evolent Health (EVH): Can Its 9.5% Jump Turn into More Strength?

Q1 Earnings Outperformers: Evolent Health (NYSE:EVH) And The Rest Of The Healthcare Technology for Providers Stocks

Evolent Health, Inc. (NYSE:EVH) Just Released Its First-Quarter Earnings: Here's What Analysts Think

Evolent Health (EVH) Reports Q1 Loss, Misses Revenue Estimates

Evolent Health (NYSE:EVH) Misses Q1 CY2026 Revenue Estimates, But Stock Soars 5.1%

Compared to Estimates, Evolent Health (EVH) Q1 Earnings: A Look at Key Metrics

Why Is Evolent Health (EVH) Stock Soaring Today

Spotting Winners: Evolent Health (NYSE:EVH) And Healthcare Technology for Providers Stocks In Q4

Evolent Health (EVH): Buy, Sell, or Hold Post Q4 Earnings?

Evolent Announces Fourth Quarter 2025 Results and Full Year 2025 Results

Take Care Before Diving Into The Deep End On Evolent Health, Inc. (NYSE:EVH)

Evolent Health Inc (EVH) Q3 2025 Earnings Call Highlights: Strong Revenue Growth Amidst Market ...

Why Evolent Health (EVH) Stock Is Nosediving